You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (45) |
Back to Search
Evaluation of Doravirine Pharmacokinetics in Pregnant Women using Physiologically-Based Pharmacokinetic Models
- At: PSWC2020 (2020)
- Type: Poster
- By: ATOYEBI, Shakir (Obafemi Awolowo University, Department of Pharmaceutical Chemistry, Nigeria)
- Co-author(s): Shakir Adeyinka Atoyebi: Department of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile Ife, Nigeria
Oluseye Bolaji: Department of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile Ife, Nigeria
Adeniyi Olagunju: Department of Pharmaceutical Chemistry, Obafemi Awolowo University, Ile Ife, Nigeria - Abstract:
Background
Doravirine (PIFELTRO) has been approved for antiretroviral therapy in adults but there are no available pharmacokinetic (PK) data in pregnant women to guide its use in pregnancy.
Purpose
To develop, qualify and deploy a physiologically-based pharmacokinetic (PBPK) model to evaluate the PK of 100 mg doravirine during pregnancy.
Methods
A.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026